InvestSMART

Acrux Limited (ASX: ACR) - Announcements

- Current share price for ACR : $0.011

ASX company news and announcements for Acrux Limited (ACR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acrux Limited (ACR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acrux Limited (ACR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acrux Limited (ACR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Appendix 4E and 2017 Financial Report 22 Aug 2017 5:02PM $0.255 $0.011 fallen by 95.69%
$7 Investor Conference Call 2017 Annual Results 22 Aug 2017 4:12PM $0.255 $0.011 fallen by 95.69%
$7 Teva Launches Generic Version of Axiron in United States 21 Aug 2017 10:04AM $0.265 $0.011 fallen by 95.85%
$7 Axiron Net Sales Quarter to 30 June 2017 26 Jul 2017 8:24AM $0.290 $0.011 fallen by 96.21%
$7 Acrux Presents At Bioshares Biotech Summit 24 Jul 2017 9:48AM $0.280 $0.011 fallen by 96.07%
$7 Axiron Generic Launched In The United States 6 Jul 2017 9:44AM $0.230 $0.011 fallen by 95.22%
$7 Institution of IPR Proceeding Against Key Jublia Patent 2 May 2017 11:14AM $0.280 $0.011 fallen by 96.07%
$7 Axiron Net Sales Quarter to 31 March 2017 26 Apr 2017 9:07AM $0.275 $0.011 fallen by 96%
$7 S&P DJ Indices Announces March Quarterly Rebalance 10 Mar 2017 8:19AM $0.290 $0.011 fallen by 96.21%
$7 Ceasing to be a substantial holder 28 Feb 2017 4:40PM $0.285 $0.011 fallen by 96.14%
$7 Investor Presentation 17 Feb 2017 4:25PM $0.305 $0.011 fallen by 96.39%
$7 Appendix 4D and Half Year Report to 31 December 2016 17 Feb 2017 3:59PM $0.305 $0.011 fallen by 96.39%
$7 Investor Call December 16 HY Results Updated Dial-In Details 14 Feb 2017 10:45AM $0.300 $0.011 fallen by 96.33%
$7 Change in substantial holding 3 Feb 2017 5:07PM $0.310 $0.011 fallen by 96.45%
$7 Change in substantial holding 1 Feb 2017 4:34PM $0.320 $0.011 fallen by 96.56%
$7 Axiron Net Sales, Quarter to December2016 1 Feb 2017 9:47AM $0.310 $0.011 fallen by 96.45%
$7 Appendix 3B 30 Jan 2017 10:05AM $0.320 $0.011 fallen by 96.56%
$7 Half-Year Results Investor Conference Call 25 Jan 2017 3:38PM $0.315 $0.011 fallen by 96.51%
$7 Change in substantial holding 19 Jan 2017 4:33PM $0.310 $0.011 fallen by 96.45%
$7 Final Director Interest Notice 8 Dec 2016 3:27PM $0.305 $0.011 fallen by 96.39%
$7 Resignation of Director 8 Dec 2016 3:25PM $0.305 $0.011 fallen by 96.39%
$7 Change of Director's Interest Notice 18 Nov 2016 8:43AM $0.330 $0.011 fallen by 96.67%
$7 2016 AGM Script 10 Nov 2016 9:51AM $0.330 $0.011 fallen by 96.67%
$7 2016 AGM Presentation 10 Nov 2016 9:50AM $0.330 $0.011 fallen by 96.67%
$7 2016 AGM Results of Meeting 10 Nov 2016 12:52AM $0.345 $0.011 fallen by 96.81%

451 - 475 of 706 results

Page 19 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.